The Secretary of State for Environment, Food and Rural Affairs
has, on 4 September, permitted the use of 3 unauthorised
bluetongue serotype 3 (BTV-3) vaccines within the United Kingdom.
These vaccines cannot be used without an appropriate licence
being in place.
Further information on the specific licences granted, vaccines
and permit requirements for these products is available on the
Defra pages under; Bluetongue
serotype 3 (BTV-3) vaccine permits - GOV.UK
(publishing.service.gov.uk)
Should you wish to use any BTV-3 vaccine, please contact your
private veterinarian.
Further information and updates regarding BTV is available on;
Bluetongue: news,
information and guidance for livestock keepers - GOV.UK
(www.gov.uk)
Pharmacovigilance reporting
Manufacturers of these products are reminded that reports of
suspected adverse events after the use of BTV3 vaccines,
including suspected lack of efficacy, must be submitted to the
VMD within 10 - 15 calendar days of awareness via your electronic
reporting system.
If you are a veterinary surgeon or animal keeper you should
report a suspected problem within 7 calendar days to either the
relevant pharmaceutical company (as detailed on the package
leaflet) or to the VMD (Report a suspected problem with
an animal medicine or microchip: Overview - GOV.UK
(www.gov.uk)).
For any questions regarding the procedure for reporting adverse
events, please use the following email: adverse.events@vmd.gov.uk.
